Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed250%
withdrawn250%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnnot_applicable

Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.

NCT01276002
completednot_applicable

The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis

NCT03643900
completed

Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing PEP

NCT04340687
withdrawnnot_applicable

Pancreatic Stent to Prevent Leak After Distal Pancreatectomy

NCT00671463

Clinical Trials (4)

Showing 4 of 4 trials
NCT01276002Not Applicable

Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.

Withdrawn
NCT03643900Not Applicable

The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis

Completed
NCT04340687

Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing PEP

Completed
NCT00671463Not Applicable

Pancreatic Stent to Prevent Leak After Distal Pancreatectomy

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4